Stay updated on Avelumab and Palbociclib in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.

Latest updates to the Avelumab and Palbociclib in Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s footer application/version indicator updates from revision v3.5.2 to v3.5.3, indicating a platform release rather than changes to the clinical trial record itself.SummaryDifference0.1%

- Check23 days agoChange DetectedThe record history now includes revision v3.5.2 and removes revision v3.5.0. This is a metadata update to the history log rather than substantive study information.SummaryDifference0.1%

- Check30 days agoChange DetectedThe PALAVY study record title was updated to 'Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)'. The update also adds IPDSharing, Study Status, and Study Identification fields, replacing the prior title variant.SummaryDifference0.7%

- Check52 days agoChange DetectedRevision: v3.5.0 was added to the Record History. Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision v3.4.3 was added to the Study Record Versions, and revision v3.4.2 was removed.SummaryDifference0.1%

- Check88 days agoChange DetectedA new revision entry v3.4.2 was added to the history and v3.4.1 was removed from the list.SummaryDifference0.1%

Stay in the know with updates to Avelumab and Palbociclib in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.